Intelligence Platform
Patents
Browse 3,494 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 8026284
Enterically coated cystamine, cysteamine and derivatives thereof
granted patentUS 8026263
Methods for inhibiting neoproliferative changes in blood vessel walls
granted patentUS 8022052
Inhibition of PPAR gamma expression by specific osteogenic oxysterols
granted patentUS 8021644
Methods for measuring rates of reverse cholesterol transport in vivo, as an index of anti-
granted patentUS 8021673
Proteins with repetitive Bacterial-Ig-like (Big) domains present in Leptospira species
granted patentUS 8022040
Hydroxyapatite-binding peptides for bone growth and inhibition
granted patentUS 8017135
Lipid-drug conjugates for local therapy of eye diseases
granted patentUS 8012739
Methods and compositions for the production of orthogonal tRNA-aminoacyl-tRNA synthetase p
granted patentUS 8008353
Methods for modulating macrophage proliferation using polyamine analogs
granted patentUS 8008308
Phosphonate compounds
granted patentUS 8007778
Use of calcium binding proteins to improve cardiac contractile function
granted patentUS 8008510
Metalloprotein inhibitors
granted patentUS 8003693
Modulation of anxiety through blockade of anandamide hydrolysis
granted patentUS 7998481
Modulation of NKG2D for treating or preventing solid organ allograft rejection
granted patentUS 7998923
Bioactivation of particles
granted patentUS 7998928
Method of treatment of type-1 diabetes with a humanin analogue
granted patentUS 7999079
Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
granted patentUS 7994143
Metabolically stable alkoxyalkyl esters of antiviral or antiproliferative phosphonates, nu
granted patentUS 7993866
Diagnosis, prevention and treatment of crohn's disease using the OmpC antigen
granted patentUS 7993865
Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen
granted patentUS 7993867
Diagnosis, prevention and treatment of crohn's disease using the OmpC antigen
granted patentUS 7994226
Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine products
granted patentUS 7994132
Peptides for treatment of scleroderma
granted patentUS 7985783
Aldehyde tags, uses thereof in site-specific protein modification
granted